Red-Hot Pharma Space Produces 2016's First Megadeal
The deal-hungry pharmaceutical space came out swinging in the New Year as Irish drugmaker Shire's $32 billion play for rare disease biotech Baxalta became 2016's first megadeal, signaling another busy year...To view the full article, register now.
Already a subscriber? Click here to view full article